GO:1904831 positive regulation of aortic smooth muscle cell differentiation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904831 describes any process that activates or increases the frequency, rate or extent of aortic smooth muscle cell differentiation [QuickGO].
• Aortic smooth muscle cell (ASMC) differentiation is controlled by transcription factors such as c-Myb, GATA6, and KLF4, which integrate developmental and stress signals.
• Phenotype switching of ASMCs from a contractile to a synthetic state is a hallmark of vascular disease, including aortic aneurysm and atherosclerosis.
• Mechanical forces and extracellular matrix stiffness regulate ASMC differentiation through SM22α/Transgelin and related cytoskeletal proteins.
• Epigenetic and metabolic signals, including H19/AMPK and GDF11, modulate ASMC differentiation and calcification.
• CRISPR-based knockout, knock-in, and overexpression models are essential to establish causality of candidate genes in ASMC differentiation.
Description
Aortic smooth muscle cells (ASMCs) are the predominant cell type in the aortic media, where they maintain vascular tone and structural integrity. The process by which these cells acquire their specialized contractile phenotype is termed aortic smooth muscle cell differentiation, and its positive regulation is annotated under the Gene Ontology term GO:1904831. This term encompasses any molecular event that activates or increases the frequency, rate, or extent of ASMC differentiation [QuickGO]. Understanding this process is critical because defective or excessive ASMC differentiation contributes to major aortic pathologies, including aneurysm, atherosclerosis, and calcification. Research over the past two decades has identified a network of transcription factors, epigenetic modifiers, and signaling pathways that drive ASMC differentiation. For example, c-Myb is required for smooth muscle cell differentiation during development, while GATA6 accelerates senescence-related arterial calcification by counteracting SIRT6. Mechanical cues also play a central role: SM22α/Transgelin, a cytoskeletal protein, is mechanoregulated and serves as a marker of differentiated ASMCs. Despite these advances, the precise molecular mechanisms that positively regulate ASMC differentiation remain incompletely understood. This article synthesizes current knowledge based on QuickGO annotations and verified PubMed literature, providing a research-grade overview for scientists studying vascular biology, disease modeling, and therapeutic targeting.
positive regulation of aortic smooth muscle cell differentiation At A Glance
| GO ID | GO:1904831 |
|---|---|
| GO term | positive regulation of aortic smooth muscle cell differentiation |
| Ontology | biological_process |
| Synonym | activation of aortic smooth muscle cell differentiation; up regulation of aortic smooth muscle cell differentiation; up-regulation of aortic smooth muscle cell differentiation; upregulation of aortic smooth muscle cell differentiation |
| Major function | Promotes the differentiation of aortic smooth muscle cells into contractile, mature cells |
| Related processes | Smooth muscle cell differentiation, vascular development, extracellular matrix organization |
| Disease relevance | Aortic aneurysm, atherosclerosis, vascular calcification, arterial stiffness |
| Research tools | CRISPR knockout/knock-in, overexpression, RNA-seq, ChIP-seq, proteomics |
What Is GO:1904831?
GO:1904831, positive regulation of aortic smooth muscle cell differentiation, is a biological process term defined as any process that activates or increases the frequency, rate or extent of aortic smooth muscle cell differentiation. In other words, it covers all molecular signals, transcription factors, and environmental cues that promote the transition of aortic smooth muscle cells toward a differentiated, contractile phenotype.
Why Is positive regulation of aortic smooth muscle cell differentiation Important in Cell Biology?
Positive regulation of aortic smooth muscle cell differentiation is essential for maintaining aortic wall integrity and function. Dysregulation of this process leads to phenotype switching, where ASMCs lose contractile markers and adopt synthetic, proliferative, or osteogenic phenotypes, contributing to aneurysm, atherosclerosis, and calcification. Therefore, understanding the positive regulators of ASMC differentiation provides mechanistic insights into vascular disease and identifies potential therapeutic targets.
• Maintains the contractile phenotype of aortic smooth muscle cells, which is critical for vascular tone and blood pressure regulation.
• Prevents pathological phenotype switching that underlies aortic aneurysm and dissection.
• Counteracts vascular calcification by inhibiting osteogenic differentiation of ASMCs.
• Integrates mechanical and biochemical signals to adapt aortic wall structure to hemodynamic demands.
• Involves transcription factors such as c-Myb, GATA6, and KLF4 that are amenable to CRISPR editing.
• Epigenetic regulators like H19 and AMPK modulate ASMC differentiation and atherosclerotic calcification.
• GDF11 signaling regulates ASMC phenotype switching and prevents aneurysm formation.
• Provides biomarkers (e.g., SM22α, MYH11) for assessing differentiation status in vitro and in vivo.
• Offers targets for drug discovery aimed at stabilizing the contractile phenotype in vascular disease.
• Enables disease modeling using patient-derived induced pluripotent stem cells and CRISPR-corrected lines.
What Happens During positive regulation of aortic smooth muscle cell differentiation?
Transcriptional activation of contractile genes
In simple terms: Certain proteins turn on the genes that make smooth muscle cells contractile.
The positive regulation of ASMC differentiation begins with the activation of transcription factors that bind to promoter or enhancer regions of contractile genes such as ACTA2, MYH11, and TAGLN (SM22α). c-Myb is a key transcription factor required for smooth muscle cell differentiation, as demonstrated by loss-of-function studies showing impaired differentiation. GATA6, on the other hand, can accelerate senescence-related arterial calcification by counteracting SIRT6, indicating a complex role in differentiation and aging. These transcription factors coordinate the expression of a contractile gene program that defines the differentiated ASMC phenotype.
Mechanical and cytoskeletal signaling
In simple terms: Physical forces on the cell help it become a mature smooth muscle cell.
Mechanical cues from blood flow and extracellular matrix stiffness are translated into biochemical signals that promote ASMC differentiation. SM22α/Transgelin, an actin-binding protein, is mechanoregulated and serves both as a marker and a modulator of the differentiated state. Cyclic stretch and shear stress activate signaling pathways that reinforce the contractile phenotype, while loss of mechanical support leads to dedifferentiation. This mechanotransduction involves integrins, focal adhesion kinases, and RhoA/ROCK signaling, although the exact mechanisms continue to be investigated.
Epigenetic and metabolic regulation
In simple terms: Chemical tags on DNA and energy sensors in the cell influence how smooth muscle cells mature.
Epigenetic modifications, including DNA methylation and histone acetylation, regulate the accessibility of contractile gene loci. For instance, epigenetic upregulation of H19 and inhibition of AMPK concurrently contribute to S-adenosylhomocysteine hydrolase deficiency-promoted atherosclerotic calcification, a process linked to impaired ASMC differentiation. Metabolic sensors such as AMPK integrate energy status with differentiation signals, and their dysregulation can shift ASMCs toward osteogenic or synthetic phenotypes.
Growth factor and cytokine signaling
In simple terms: External signals from growth factors tell smooth muscle cells to mature or stay immature.
Growth factors such as GDF11 regulate ASMC phenotype switching to prevent aortic aneurysm formation. GDF11 belongs to the TGF-β superfamily and promotes the contractile phenotype while inhibiting synthetic switching. In contrast, inflammatory cytokines and microbial products, such as Prevotella copri lipopolysaccharide, can activate NF-κB signaling and promote vascular calcification, indirectly opposing ASMC differentiation. The balance between pro-differentiation and pro-inflammatory signals determines the fate of ASMCs in health and disease.
Osteogenic differentiation and calcification
In simple terms: When smooth muscle cells turn into bone-like cells, it leads to calcification.
Positive regulation of ASMC differentiation is inversely related to osteogenic differentiation. The RCN2/STAT3/miR-155-5p feedback loop induces osteogenic differentiation and calcification of human aortic smooth muscle cells, indicating that disruption of the contractile program promotes calcification. Similarly, high estrogen induces trans-differentiation of vascular smooth muscle cells to a macrophage-like phenotype via inhibiting the VHL/HIF1a/KLF4 axis, resulting in aortic inflammation. These findings highlight that maintaining positive regulation of ASMC differentiation is protective against pathological calcification and inflammation.
Key Genes Involved in GO:1904831 positive regulation of aortic smooth muscle cell differentiation
The following genes and proteins have been experimentally implicated in the positive regulation of aortic smooth muscle cell differentiation, based on verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| c-Myb | Transcription factor required for smooth muscle cell differentiation | Loss-of-function impairs differentiation; target for knockout studies |
| GATA6 | Transcription factor that accelerates senescence-related arterial calcification | Counteracts SIRT6; modulates differentiation and aging |
| SM22α (TAGLN) | Actin-binding protein and marker of differentiated ASMCs | Mechanoregulated; used as differentiation marker |
| H19 | Long non-coding RNA involved in epigenetic regulation | Upregulation contributes to atherosclerotic calcification |
| AMPK | Energy sensor kinase | Inhibition contributes to calcification; modulates differentiation |
| GDF11 | Growth factor of TGF-β superfamily | Regulates phenotype switching; prevents aneurysm |
| KLF4 | Transcription factor | Inhibited by VHL/HIF1a axis; involved in trans-differentiation |
| VHL | E3 ubiquitin ligase | Regulates HIF1a/KLF4 axis; affects ASMC phenotype |
| HIF1a | Hypoxia-inducible factor | Mediates effects of estrogen on ASMC trans-differentiation |
| RCN2 | Reticulocalbin 2, calcium-binding protein | Part of RCN2/STAT3/miR-155-5p loop in osteogenic differentiation |
| STAT3 | Signal transducer and activator of transcription | Involved in osteogenic differentiation and calcification |
| miR-155-5p | MicroRNA | Feedback loop with RCN2/STAT3; promotes calcification |
| SIRT6 | NAD+-dependent deacetylase | Anti-aging factor counteracted by GATA6 |
| NF-κB | Transcription factor complex | Activated by Prevotella copri LPS; promotes calcification |
| Prevotella copri | Gut microbe | Promotes vascular calcification via LPS and NF-κB |
| MYH11 | Smooth muscle myosin heavy chain | Contractile marker; target of differentiation programs |
| ACTA2 | Alpha smooth muscle actin | Contractile marker; regulated during differentiation |
How Is positive regulation of aortic smooth muscle cell differentiation Regulated?
The positive regulation of aortic smooth muscle cell differentiation is controlled by a multilayered regulatory network. At the transcriptional level, c-Myb and GATA6 directly activate or repress contractile gene programs. Epigenetic modifiers, including H19 and AMPK, influence chromatin accessibility and metabolic state. Growth factor signaling through GDF11 and TGF-β superfamily members promotes the contractile phenotype. In contrast, inflammatory signals such as Prevotella copri lipopolysaccharide activate NF-κB and oppose differentiation. Mechanical forces acting through SM22α/Transgelin and cytoskeletal dynamics provide continuous feedback. Dysregulation of these pathways leads to phenotype switching, calcification, and aneurysm formation.
positive regulation of aortic smooth muscle cell differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GDF11 | Aortic aneurysm | Knockout mouse or ASMC-specific overexpression |
| GATA6 | Arterial calcification | Point mutation or knockout in human ASMCs |
| H19 | Atherosclerotic calcification | Overexpression and knockout in ASMCs |
| RCN2/STAT3/miR-155-5p | Vascular calcification | Knockdown or knockout in human aortic SMCs |
| KLF4/VHL/HIF1a | Aortic inflammation | Knock-in of degradation-resistant HIF1a |
Aortic Aneurysm
Loss of positive regulation of ASMC differentiation contributes to aortic aneurysm formation. GDF11 regulates vascular smooth muscle cell phenotype switching to prevent aortic aneurysm, and its downregulation is associated with aneurysm progression. Similarly, c-Myb-dependent differentiation is essential for maintaining aortic wall integrity, and its disruption may predispose to aneurysm.
Vascular Calcification and Atherosclerosis
Pathological calcification of the aorta is driven by osteogenic differentiation of ASMCs, which is inversely related to positive regulation of ASMC differentiation. GATA6 accelerates senescence-related arterial calcification by counteracting SIRT6. Epigenetic upregulation of H19 and AMPK inhibition promote atherosclerotic calcification. The RCN2/STAT3/miR-155-5p feedback loop induces osteogenic differentiation and calcification of human aortic smooth muscle cells. Prevotella copri promotes vascular calcification via lipopolysaccharide through activation of NF-κB signaling.
Aortic Inflammation and Trans-differentiation
High estrogen induces trans-differentiation of vascular smooth muscle cells to a macrophage-like phenotype via inhibiting the VHL/HIF1a/KLF4 axis, resulting in aortic inflammation. This trans-differentiation represents a failure of positive regulation of ASMC differentiation and contributes to inflammatory vascular disease.
From positive regulation of aortic smooth muscle cell differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is gene X required for ASMC differentiation? | CRISPR knockout in primary human aortic SMCs or iPSC-derived SMCs |
| Does a specific point mutation in gene Y alter differentiation? | CRISPR point mutation knock-in (e.g., SIRT6 mutants) |
| Does overexpression of gene Z promote differentiation? | Lentiviral or CRISPR activation overexpression in ASMCs |
| Does a tag affect protein localization during differentiation? | CRISPR tagged knock-in (e.g., GFP-SM22α) |
| Which regulatory elements control gene expression? | CRISPR interference or epigenetic editing at enhancers |
| Can a candidate gene rescue calcification? | Knock-in of wild-type vs. mutant in calcifying ASMC models |
How to Study the positive regulation of aortic smooth muscle cell differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcriptome changes | Identify contractile gene upregulation during differentiation |
| ChIP-seq | Histone modifications and TF binding | Map active enhancers at contractile loci |
| ATAC-seq | Chromatin accessibility | Detect open regions during differentiation |
| Proteomics | Protein abundance and modifications | Quantify SM22α and MYH11 protein levels |
| Immunofluorescence | Protein localization and filament formation | Visualize contractile apparatus |
| Alizarin Red staining | Calcification | Assess osteogenic differentiation |
| Calcium imaging | Intracellular calcium flux | Measure functional contractility |
| Scratch wound assay | Cell migration | Evaluate synthetic phenotype |
Transcriptomic Profiling
RNA sequencing (RNA-seq) is widely used to measure global gene expression changes during ASMC differentiation. Contractile markers such as ACTA2, MYH11, and TAGLN are upregulated, while synthetic markers are downregulated. Single-cell RNA-seq can resolve heterogeneity in ASMC populations and identify subpopulations undergoing differentiation.
Epigenomic and Chromatin Analysis
ChIP-seq for histone modifications (e.g., H3K27ac, H3K4me3) and DNA methylation assays (bisulfite sequencing) reveal epigenetic changes at contractile gene loci. H19 and AMPK-related pathways have been studied using these methods. ATAC-seq can identify open chromatin regions that become accessible during differentiation.
Proteomic and Imaging Approaches
Mass spectrometry-based proteomics quantifies protein abundance and post-translational modifications. Immunofluorescence for SM22α and MYH11 visualizes contractile filament formation. Live-cell imaging of tagged proteins (e.g., GFP-SM22α) allows dynamic monitoring of differentiation in real time.
Functional Assays
Calcium imaging, contractility assays, and scratch wound migration tests assess functional differentiation. Calcification is quantified by Alizarin Red staining and calcium content assays. These methods are essential to confirm that observed molecular changes translate into physiological ASMC functions.
How CRISPR Can Be Used to Study GO:1904831 positive regulation of aortic smooth muscle cell differentiation
Knockout
CRISPR knockout of candidate genes such as c-Myb or GATA6 in human aortic SMCs or iPSC-derived SMCs can establish whether they are required for differentiation. Loss of c-Myb impairs smooth muscle cell differentiation, and GATA6 knockout affects calcification and senescence. Knockout models are essential for causal inference.
Point Mutation
Point mutations can mimic disease-associated variants or disrupt specific domains. For example, mutation of SIRT6 at catalytic residues can test its role in counteracting GATA6-mediated calcification. CRISPR base editors enable precise introduction of such mutations without double-strand breaks.
Knock-in
Knock-in of tagged proteins (e.g., GFP-SM22α) allows real-time tracking of differentiation. Knock-in of disease-relevant mutations, such as those in HIF1a that resist VHL-mediated degradation, can model aortic inflammation. Knock-in of reporter genes under contractile promoters enables high-throughput screening.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of pro-differentiation genes such as GDF11 can promote the contractile phenotype and prevent aneurysm in models. Overexpression of H19 or AMPK mutants can test their sufficiency in driving calcification.
How EDITGENE Supports positive regulation of aortic smooth muscle cell differentiation Research
Researchers studying positive regulation of aortic smooth muscle cell differentiation-related genes often need to determine whether a candidate gene is causally involved in the differentiation process. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from knockout to precise point mutations and overexpression.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of aortic smooth muscle cell differentiation research.
Frequently Asked Questions About positive regulation of aortic smooth muscle cell differentiation
What is GO:1904831?
GO:1904831 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of aortic smooth muscle cell differentiation.
What genes are involved in positive regulation of aortic smooth muscle cell differentiation?
Key genes include c-Myb, GATA6, SM22α (TAGLN), H19, AMPK, GDF11, KLF4, VHL, HIF1a, RCN2, STAT3, and miR-155-5p, among others.
How is aortic smooth muscle cell differentiation regulated?
It is regulated by transcription factors (c-Myb, GATA6), epigenetic modifiers (H19, AMPK), growth factors (GDF11), mechanical cues (SM22α), and inflammatory signals (NF-κB).
What diseases are associated with defective aortic smooth muscle cell differentiation?
Aortic aneurysm, atherosclerosis, vascular calcification, and aortic inflammation are associated with dysregulated ASMC differentiation.
What research methods are used to study positive regulation of ASMC differentiation?
Common methods include RNA-seq, ChIP-seq, ATAC-seq, proteomics, immunofluorescence, calcium imaging, and CRISPR-based functional assays.
How can CRISPR be used to study ASMC differentiation?
CRISPR knockout, knock-in, point mutation, and overexpression models allow causal testing of candidate genes in ASMC differentiation.
What is the role of SM22α in ASMC differentiation?
SM22α/Transgelin is a mechanoregulated actin-binding protein and a marker of differentiated ASMCs.
How does GDF11 affect aortic smooth muscle cells?
GDF11 regulates vascular smooth muscle cell phenotype switching to prevent aortic aneurysm formation.
What is the link between H19 and vascular calcification?
Epigenetic upregulation of H19 and AMPK inhibition concurrently contribute to S-adenosylhomocysteine hydrolase deficiency-promoted atherosclerotic calcification.
Can EDITGENE help with CRISPR models for ASMC differentiation?
Yes, EDITGENE provides knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services for ASMC differentiation research.
Conclusion
GO:1904831, positive regulation of aortic smooth muscle cell differentiation, is a critical biological process that maintains aortic wall integrity and prevents vascular disease. The integration of transcriptional, epigenetic, mechanical, and growth factor signals ensures proper ASMC differentiation, while their dysregulation leads to aneurysm, calcification, and inflammation. Continued research using CRISPR-based models and multi-omics approaches will further elucidate these mechanisms and identify therapeutic targets.
References
- 1. Li X et al.. 2024. The transcription factor GATA6 accelerates vascular smooth muscle cell senescence-related arterial calcification by counteracting the role of anti-aging factor SIRT6 and impeding DNA damage repair.. Kidney Int 105(1):115-131 PMID: 37914087
- 2. Hao QY et al.. 2024. Prevotella copri promotes vascular calcification via lipopolysaccharide through activation of NF-κB signaling pathway.. Gut Microbes 16(1):2351532 PMID: 38727248
- 3. Liu R et al.. 2017. Mechanoregulation of SM22α/Transgelin.. Biochemistry 56(41):5526-5538 PMID: 28898058
- 4. Dai X et al.. 2022. Epigenetic Upregulation of H19 and AMPK Inhibition Concurrently Contribute to S-Adenosylhomocysteine Hydrolase Deficiency-Promoted Atherosclerotic Calcification.. Circ Res 130(10):1565-1582 PMID: 35410483
- 5. Su X et al.. 2026. GDF11 Regulates Vascular Smooth Muscle Cell Phenotype Switching to Prevent Aortic Aneurysm Formation.. Cardiovasc Drugs Ther 40(3):883-895 PMID: 41240221
- 6. Kolodziejska KM et al.. 2008. c-Myb-dependent smooth muscle cell differentiation.. Circ Res 102(5):554-61 PMID: 18187733
- 7. Zhang R et al.. 2024. High estrogen induces trans-differentiation of vascular smooth muscle cells to a macrophage-like phenotype resulting in aortic inflammation via inhibiting VHL/HIF1a/KLF4 axis.. Aging (Albany NY) 16(11):9876-9898 PMID: 38843385
- 8. Zhao J et al.. 2021. Osteogenic differentiation and calcification of human aortic smooth muscle cells is induced by the RCN2/STAT3/miR-155-5p feedback loop.. Vascul Pharmacol 136:106821 PMID: 33221530
